BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26338823)

  • 1. Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy.
    Hata M; Tsujikawa A; Yoshimura N
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1021-2. PubMed ID: 26338823
    [No Abstract]   [Full Text] [Related]  

  • 2. One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.
    Cheng CK; Peng CH; Chang CK; Hu CC; Chen LJ
    Retina; 2011 May; 31(5):846-56. PubMed ID: 21317837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasticity of polypoidal lesions in polypoidal choroidal vasculopathy.
    Okubo A; Sameshima M; Sakamoto T
    Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):962-5. PubMed ID: 15221299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy.
    Nishijima K; Takahashi M; Akita J; Katsuta H; Tanemura M; Aikawa H; Mandai M; Takagi H; Kiryu J; Honda Y
    Am J Ophthalmol; 2004 Apr; 137(4):770-3. PubMed ID: 15059729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peripheral idiopathic polypoidal choroidal vasculopathy].
    Merle H; Donnio A; Jean-Charles A
    Can J Ophthalmol; 2007 Aug; 42(4):631-2. PubMed ID: 17641718
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy.
    Tsujikawa A; Ojima Y; Yamashiro K; Nakata I; Ooto S; Tamura H; Nakanishi H; Hayashi H; Otani A; Yoshimura N
    Am J Ophthalmol; 2011 Jun; 151(6):961-972.e1. PubMed ID: 21457926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
    Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
    Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic influence on visual outcomes of polypoidal choroidal vasculopathy.
    Tan CS; Ngo WK; Lim LW; Lim TH
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1019-20. PubMed ID: 26373548
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiographic leakage of polypoidal choroidal vasculopathy on indocyanine angiography.
    Zuo CG; Wen F; Huang SZ; Luo GW; Yan H; Wu WJ; Wu DZ
    Chin Med J (Engl); 2010 Jun; 123(12):1548-52. PubMed ID: 20819510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Chhablani J
    Am J Ophthalmol; 2010 Sep; 150(3):443-4; author reply 444. PubMed ID: 20728684
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
    Lai TY; Lee GK; Luk FO; Lam DS
    Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy.
    Lee YH; Lee EK; Shin KS; Lee KM; Kim JY
    Retina; 2011; 31(7):1287-93. PubMed ID: 21386762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing Polypoidal Choroidal Vasculopathy Without Indocyanine Green Angiography.
    Cheung CMG; Kim JE
    JAMA Ophthalmol; 2019 Jun; 137(6):667-668. PubMed ID: 30973591
    [No Abstract]   [Full Text] [Related]  

  • 14. Idiopathic polypoidal choroidal vasculopathy of the macula.
    Moorthy RS; Lyon AT; Rabb MF; Spaide RF; Yannuzzi LA; Jampol LM
    Ophthalmology; 1998 Aug; 105(8):1380-5. PubMed ID: 9709746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypoidal choroidal vasculopathy in a patient with angioid streaks secondary to pseudoxanthoma elasticum.
    Baillif-Gostoli S; Quaranta-El Maftouhi M; Mauget-Faÿsse M
    Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1845-8. PubMed ID: 20213478
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ueno C; Gomi F; Sawa M; Nishida K
    Retina; 2012; 32(10):2006-13. PubMed ID: 22772392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aflibercept for the treatment of refractory polypoidal choroidal vasculopathy.
    Yonekawa Y
    Can J Ophthalmol; 2013 Jun; 48(3):e59-60. PubMed ID: 23769799
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case report of idiopathic polypoidal choroidal vasculopathy].
    Yi C; Ou J; Yian H; Mai G; Yu Q
    Yan Ke Xue Bao; 2001 Jun; 17(2):126-9. PubMed ID: 12567768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypoidal choroidal vasculopathy in tilted disk syndrome and high myopia with staphyloma.
    Mauget-Faÿsse M; Cornut PL; Quaranta El-Maftouhi M; Leys A
    Am J Ophthalmol; 2006 Dec; 142(6):970-5. PubMed ID: 17046703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.